Metropolitan Life Insurance CO Intercept Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

  • $253 Million
  • Q2 2024

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$9.99 - $18.71 $10,849 - $20,319
1,086 Added 83.67%
2,384 $44,000
Q1 2023

May 15, 2023
SELL
$12.53 - $21.71 $4,661 - $8,076
-372 Reduced 22.28%
1,298 $17,000
Q4 2022

Jun 14, 2023
BUY
$11.61 - $16.11 $4,318 - $5,992
372 Added 28.66%
1,670 $20.7 Million
Q3 2022

Jun 14, 2023
BUY
$12.21 - $19.7 $4,542 - $7,328
372 Added 28.66%
1,670 $23.3 Million
Q2 2022

Jun 20, 2023
BUY
$11.23 - $19.59 $4,177 - $7,287
372 Added 28.66%
1,670 $23,000
Q1 2022

Jun 20, 2023
BUY
$13.37 - $17.79 $4,973 - $6,617
372 Added 28.66%
1,670 $27,000
Q1 2022

Mar 30, 2023
SELL
$13.37 - $17.79 $70,339 - $93,593
-5,261 Reduced 75.91%
1,670 $27,000
Q1 2022

May 12, 2022
SELL
$13.37 - $17.79 $70,339 - $93,593
-5,261 Reduced 75.91%
1,670 $27,000
Q4 2021

Jun 21, 2023
BUY
$14.28 - $19.53 $80,439 - $110,012
5,633 Added 433.98%
6,931 $112,000
Q4 2021

Mar 30, 2023
SELL
$14.28 - $19.53 $14,051 - $19,217
-984 Reduced 12.43%
6,931 $112,000
Q4 2021

Feb 15, 2022
SELL
$14.28 - $19.53 $14,051 - $19,217
-984 Reduced 12.43%
6,931 $113,000
Q3 2021

Jun 21, 2023
BUY
$12.99 - $20.47 $85,954 - $135,449
6,617 Added 509.78%
7,915 $117,000
Q2 2021

Jun 21, 2023
BUY
$15.46 - $24.5 $102,298 - $162,116
6,617 Added 509.78%
7,915 $158,000
Q2 2021

Aug 16, 2021
BUY
$15.46 - $24.5 $122,242 - $193,721
7,907 Added 98837.5%
7,915 $158,000
Q1 2021

Jun 26, 2023
BUY
$19.33 - $37.75 $127,906 - $249,791
6,617 Added 509.78%
7,915 $183 Million
Q1 2021

May 14, 2021
SELL
$19.33 - $37.75 $152,842 - $298,489
-7,907 Reduced 99.9%
8 $183,000
Q4 2020

Jun 22, 2023
BUY
$24.48 - $42.47 $161,984 - $281,023
6,617 Added 509.78%
7,915 $195,000
Q3 2020

Jun 26, 2023
BUY
$39.09 - $53.44 $258,658 - $353,612
6,617 Added 509.78%
7,915 $328,000
Q2 2020

Jun 26, 2023
BUY
$46.7 - $92.04 $309,013 - $609,028
6,617 Added 509.78%
7,915 $379,000
Q2 2020

Mar 30, 2023
BUY
$46.7 - $92.04 $20,221 - $39,853
433 Added 5.79%
7,915 $379,000
Q2 2020

Aug 14, 2020
BUY
$46.7 - $92.04 $20,221 - $39,853
433 Added 5.79%
7,915 $379,000
Q1 2020

Jul 12, 2023
BUY
$48.35 - $118.68 $298,996 - $733,917
6,184 Added 476.43%
7,482 $471,000
Q1 2020

Mar 30, 2023
SELL
$48.35 - $118.68 $21,660 - $53,168
-448 Reduced 5.65%
7,482 $471,000
Q1 2020

May 15, 2020
SELL
$48.35 - $118.68 $21,660 - $53,168
-448 Reduced 5.65%
7,482 $471,000
Q4 2019

Jul 12, 2023
BUY
$57.36 - $124.1 $380,411 - $823,031
6,632 Added 510.94%
7,930 $982,000
Q4 2019

Mar 30, 2023
SELL
$57.36 - $124.1 $10,496 - $22,710
-183 Reduced 2.26%
7,930 $982,000
Q4 2019

Feb 14, 2020
SELL
$57.36 - $124.1 $10,496 - $22,710
-183 Reduced 2.26%
7,930 $983,000
Q3 2019

Jul 12, 2023
BUY
$58.69 - $80.46 $399,972 - $548,334
6,815 Added 525.04%
8,113 $538,000
Q3 2019

Mar 30, 2023
BUY
$58.69 - $80.46 $55,344 - $75,873
943 Added 13.15%
8,113 $538,000
Q3 2019

Nov 14, 2019
BUY
$58.69 - $80.46 $55,344 - $75,873
943 Added 13.15%
8,113 $538,000
Q2 2019

Jul 12, 2023
BUY
$77.77 - $120.68 $472,141 - $732,648
6,071 Added 467.72%
7,369 $586,000
Q1 2019

Jul 13, 2023
BUY
$91.83 - $120.68 $539,225 - $708,632
5,872 Added 452.39%
7,170 $802,000
Q1 2019

Mar 30, 2023
BUY
$91.83 - $120.68 $505,065 - $663,740
5,500 Added 329.34%
7,170 $802,000
Q1 2019

May 16, 2019
BUY
$91.83 - $120.68 $515,900 - $677,980
5,618 Added 361.98%
7,170 $802,000
Q1 2019

May 15, 2019
SELL
$91.83 - $120.68 $515,900 - $677,980
-5,618 Reduced 78.35%
1,552 $150,000
Q4 2018

Jul 13, 2023
BUY
$85.79 - $126.46 $503,758 - $742,573
5,872 Added 452.39%
7,170 $722,000
Q4 2018

Feb 14, 2019
BUY
$85.79 - $126.46 $480,424 - $708,176
5,600 Added 356.69%
7,170 $723,000
Q3 2018

Jul 13, 2023
BUY
$88.49 - $127.55 $519,613 - $748,973
5,872 Added 452.39%
7,170 $906 Million
Q3 2018

Nov 14, 2018
SELL
$88.49 - $127.55 $495,544 - $714,280
-5,600 Reduced 78.1%
1,570 $198,000
Q2 2018

Aug 15, 2018
BUY
$60.0 - $85.67 $350,040 - $499,798
5,834 Added 436.68%
7,170 $0
Q1 2018

May 15, 2018
BUY
$52.72 - $67.25 $52 - $67
1 Added 0.07%
1,336 $0
Q4 2017

Feb 15, 2018
SELL
$58.2 - $72.76 $873 - $1,091
-15 Reduced 1.11%
1,335 $78,000
Q3 2017

Nov 14, 2017
BUY
$57.01 - $118.75 $3,933 - $8,193
69 Added 5.39%
1,350 $78,000
Q2 2017

Aug 14, 2017
BUY
N/A
1,281
1,281 $155,000

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email